Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Reports describe recent advances in breast cancer research
October 13th, 2005
Data on breast cancer are outlined in reports from the E-mail: f, Lebanon and Japan. Study 1: Tamoxifen was recently compared to anastrozole for treatment of early breast cancer. Tamoxifen, which is actually the gold standard adjuvant treatment in estrogen receptor-positive early breast cancer, is associated with an increased risk of endometrial cancer and other life-threatening events," according to recent research from Italy. "Moreover, many women relapse during or after tamoxifen therapy because of the development of resistance." "Therefore new approaches are required," stated F. Boccardo and colleagues. They "conducted a...
Source: Women's Health Weekly (2005-10-13)
|
